Modelling mammalian cellular quiescence

Interface Focus

Volumn 4, Issue 3, 2014, Pages

  Yao, Guang ^a  

^a University of Arizona   (United States)

Author keywords

Bistable switch; Cell cycle; Cellular quiescence; Gene network

Indexed keywords

EID: 84899453151     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2013.0074     Document Type: Review

References (156)

1. Cheung TH, Rando TA. 2013 Molecular regulation of stem cell quiescence. Nat. Rev. Mol. Cell Biol. 14, 329-340. (doi:10.1038/nrm3591)
2. Legesse-Miller A et al. 2012 Quiescent fibroblasts are protected from proteasome inhibition-mediated toxicity. Mol. Biol. Cell 23, 3566-3581. (doi:10. 1091/mbc.E12-03-0192)
3. Coller HA, Sang L, Roberts JM. 2006 A new description of cellular quiescence. PLoS Biol. 4, e83. (doi:10.1371/journal.pbio.0040083)
4. Liu H, Adler AS, Segal E, Chang HY. 2007 A transcriptional program mediating entry into cellular quiescence. PLoS Genet. 3, 996-1008. (doi:10.1371/journal.pgen.0030091)
5. Yusuf I, Fruman DA. 2003 Regulation of quiescence in lymphocytes. Trends Immunol. 24, 380-386. (doi:10.1016/S1471-4906(03)00141-8)
6. Venezia TA, Merchant AA, Ramos CA, Whitehouse NL, Young AS, Shaw CA, Goodell MA. 2004 Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. 2, e301. (doi:10.1371/journal.pbio.0020301)
7. Sang L, Coller HA, Roberts JM. 2008 Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 321, 1095-1100. (doi:10.1126/science.1155998)
8. Lemons JMS et al. 2010 Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol. 8, e1000514. (doi:10.1371/journal.pbio.1000514)
9. Valcourt JR, Lemons JMS, Haley EM, Kojima M, Demuren OO, Coller HA. 2012 Staying alive: metabolic adaptations to quiescence. Cell Cycle 11, 1680-1696. (doi:10.4161/cc.19879)
10. Temin HM. 1971 Stimulation by serum of multiplication of stationary chicken cells. J. Cell. Physiol. 78, 161-170. (doi:10.1002/jcp. 1040780202)
11. Sander G, Pardee AB. 1972 Transport changes in synchronously growing CHO and L cells. J. Cell. Physiol. 80, 267-271. (doi:10.1002/jcp. 1040800214)
12. Rovera G, Baserga R. 1973 Effect of nutritional changes on chromatin template activity and non-histone chromosomal protein-synthesis in Wi-38 and 3t6 cells. Exp. Cell Res. 78, 118-126. (doi:10.1016/0014-4827(73)90045-1)
13. Baserga R. 1976 Multiplication and division in mammalian cells. New York, NY: M. Dekker.
14. Augenlicht LH, Baserga R. 1974 Changes in the G0 state of WI-38 fibroblasts at different times after confluence. Exp. Cell Res. 89, 255-262. (doi:10. 1016/0014-4827(74)90789-7)
15. Soprano KJ. 1994 WI-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth. J. Cell Biochem. 54, 405-414. (doi:10.1002/jcb.240540407)
16. Pardee AB. 1974 A restriction point for control of normal animal cell proliferation. Proc. Natl Acad. Sci. USA, 71, 1286-1290. (doi:10.1073/pnas. 71.4.1286)
17. Zetterberg A, Larsson O. 1985 Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl Acad. Sci. USA 82, 5365-5369. (doi:10.1073/pnas.82.16.5365)
18. Cooper S. 1987 On G0 and cell cycle controls. Bioessays 7, 220-223. (doi:10.1002/bies. 950070507)
19. Cooper S. 2003 Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points. Faseb J. 17, 333-340. (doi:10.1096/fj.02-0352rev)
20. Coller HA. 2011 Cell biology. The essence of quiescence. Science 334, 1074-1075. (doi:10.1126/ science.1216242)
21. Coller HA. 2007 What's taking so long? S-phase entry from quiescence versus proliferation. Nat. Rev. Mol. Cell Biol. 8, 667-670. (doi:10.1038/nrm2223)
22. Burns FJ, Tannock IF. 1970 On existence of a G0-phase in cell cycle. Cell Tissue Kinetics 3, 321.
23. Smith JA, Martin L. 1973 Do cells cycle. Proc. Natl Acad. Sci. USA 70, 1263-1267. (doi:10.1073/pnas. 70.4.1263)
24. Demaertelaer V, Galand P. 1975 Some properties of a G0 model of cell-cycle investigation on possible existence of natural constraints on theoretical model in steady-state conditions. Cell Tissue Kinetics 8, 11-22.
25. Shields R, Smith JA. 1977 Cells regulate their proliferation through alterations in transition-probability. J. Cell. Physiol. 91, 345-355. (doi:10. 1002/jcp.1040910304)
26. Brooks RF, Bennett DC, Smith JA. 1980 Mammalian cell cycles need two random transitions. Cell 19, 493-504. (doi:10.1016/0092-8674(80)90524-3)
27. Koch AL. 1980 Does the variability of the cell-cycle result from one or many chance events. Nature 286, 80-82. (doi:10.1038/286080a0)
28. Castor LN. 1980 A G1 rate model accounts for cell-cycle kinetics attributed to transition-probability. Nature 287, 857-859. (doi:10.1038/287857a0)
29. Cooper S. 1982 The continuum model-statistical implications. J. Theor. Biol. 94, 783-800. (doi:10. 1016/0022-5193(82)90078-9)
30. Tyson JJ, Hannsgen KB. 1985 The distributions of cell size and generation time in a model of the cell cycle incorporating size control and random transitions. J. Theor. Biol. 113, 29-62. (doi:10. 1016/S0022-5193(85)80074-6)
31. Tyson JJ, Diekmann O. 1986 Sloppy size control of the cell-division cycle. J. Theor. Biol. 118, 405-426. (doi:10.1016/S0022-5193(86)80162-X)
32. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. 1986 A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643-646. (doi:10.1038/323643a0)
33. Cobrinik D. 2005 Pocket proteins and cell cycle control. Oncogene 24, 2796-2809. (doi:10.1038/sj. onc.1208619)
34. Attwooll C, Lazzerini Denchi E, Helin K. 2004 The E2F family: specific functions and overlapping interests. EMBO J. 23, 4709-4716. (doi:10.1038/sj. emboj.7600481)
35. Sears RC, Nevins JR. 2002 Signaling networks that link cell proliferation and cell fate. J. Biol. Chem. 277, 11 617-11 620. (doi:10.1074/jbc.R10006 3200)
36. Frolov MV, Dyson NJ. 2004 Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117, 2173-2181. (doi:10. 1242/jcs.01227)
37. DeGregori J, Johnson DG. 2006 Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 6, 739-748.
38. Macaluso M, Montanari M, Giordano A. 2006 Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes. Oncogene 25, 5263-5267. (doi:10.1038/sj.onc.1209680)
39. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche D. 2001 Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21, 6484-6494. (doi:10.1128/MCB.21.19.6484-6494. 2001)
40. Nielsen SJ et al. 2001 Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-565. (doi:10.1038/35087620)
41. Trojer P et al. 2007 L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 129, 915-928. (doi:10.1016/j.cell.2007.03.048)
42. Litovchick L et al. 2007 Evolutionary conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol. Cell 26, 539-551. (doi:10.1016/j. molcel.2007.04.015)
43. Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR. 1996 The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol. Cell. Biol. 16,6965-6976.
44. Leung JY, Ehmann GL, Giangrande PH, Nevins JR. 2008 A role for Myc in facilitating transcription activation by E2F1. Oncogene 27, 4172-4179. (doi:10.1038/onc.2008.55)
45. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. 1996 Cyclin D1 expression is regulated positively by the p42/p44(MAPK) and negatively by the p38/HOG(MAPK) pathway. J. Biol. Chem. 271, 20 608-20 616. (doi:10.1074/jbc.271.34.20608)
46. Aktas H, Cai H, Cooper GM. 1997 Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17, 3850-3857.
47. Kerkhoff E, Rapp UR. 1997 Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17, 2576-2586.
48. Cheng M, Sexl V, Sherr CJ, Roussel MF. 1998 Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase (MEK1). Proc. Natl Acad. Sci. USA 95, 1091-1096. (doi:10.1073/pnas.95.3.1091)
49. Harbour JW, Luo RX, Santi AD, Postigo AA, Dean DC. 1999 Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859-869. (doi:10.1016/S0092-8674(00)81519-6)
50. Wu L et al. 2001 The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414, 457-462. (doi:10.1038/35106593)
51. Johnson DG, Schwarz JK, Cress WD, Nevins JR. 1993 Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349-352. (doi:10.1038/365349a0)
52. Nevins JR. 2001 The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10, 699-703. (doi:10.1093/hmg/ 10.7.699)
53. Ladha MH, Lee KY, Upton TM, Reed MF, Ewen ME. 1998 Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18, 6605-6615.
54. Boonstra J. 2003 Progression through the G(1)-phase of the on-going cell cycle. J. Cell. Biochem. 90, 244-252. (doi:10.1002/jcb.10617)
55. Pajalunga D, Mazzola A, Salzano AM, Biferi MG, De Luca G, Crescenzi M. 2007 Critical requirement for cell cycle inhibitors in sustaining nonproliferative states. J. Cell Biol. 176, 807-818. (doi:10.1083/jcb. 200608109)
56. Spencer SL, Cappell SD, Tsai F-C, Overton KW, Wang CL, Meyer T. 2013 The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell 155, 369-383. (doi:10.1016/j.cell. 2013.08.062)
57. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M. 2000 Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804-1808. (doi:10.1126/science.287.5459.1804)
58. Sherr CJ, Roberts JM. 1995 Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163. (doi:10.1101/gad.9.10.1149)
59. Coats S, Flanagan WM, Nourse J, Roberts JM. 1996 Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877-880. (doi:10.1126/science.272.5263.877)
60. Mayol X, Grana X. 1998 The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions. Front. Biosci. 3, d11-d24.
61. Stevaux O, Dyson NJ. 2002 A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14, 684-691. (doi:10.1016/S0955-0674(02)00388-5)
62. Vidal A, Koff A. 2000 Cell-cycle inhibitors: three families united by a common cause. Gene 247, 1-15. (doi:10.1016/S0378-1119(00) 00092-5)
63. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. 2002 A complex with chromatin modifiers that occupies E2Fand Myc-responsive genes in G(0) cells. Science 296, 1132-1136. (doi:10.1126/science.1069861)
64. Rivard N, L'Allemain G, Bartek J, Pouyssegur J. 1996 Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 271, 18 337-18 341. (doi:10.1074/ jbc.271.31.18337)
65. Nakanishi M, Adami GR, Robetorye RS, Noda A, Venable SF, Dimitrov D, Pereira-Smith OM, Smith JR. 1995 Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc. Natl Acad. Sci. USA 92, 4352-4356. (doi:10.1073/pnas. 92.10.4352)
66. Kippin TE, Martens DJ, van der Kooy D. 2005 p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev. 19, 756-767. (doi:10.1101/gad.1272305)
67. Dannenberg JH, van Rossum A, Schuijff L, te Riele H. 2000 Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14, 3051-3064. (doi:10. 1101/gad.847700)
68. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegué E, Sage J. 2008 Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 3, 416-428. (doi:10.1016/j.stem. 2008.07.009)
69. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E, Jacks T. 2000 Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14, 3037-3050. (doi:10.1101/gad.843200)
70. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. 2003 Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228. (doi:10.1038/nature01764)
71. Xiong W, Ferrell Jr JE. 2003 A positive-feedback-based bistable 'memory module' that governs a cell fate decision. Nature 426, 460-465. (doi:10.1038/ nature02089)
72. Sha W, Moore J, Chen K, Lassaletta AD, Yi C-S, Tyson JJ, Sible JC. 2003 Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proc. Natl Acad. Sci. USA 100, 975-980. (doi:10.1073/pnas. 0235349100)
73. Ozbudak EM, Thattai M, Lim HN, Shraiman BI, Van Oudenaarden A. 2004 Multistability in the lactose utilization network of Escherichia coli. Nature 427, 737-740. (doi:10.1038/nature02298)
74. Paliwal S, Iglesias PA, Campbell K, Hilioti Z, Groisman A, Levchenko A. 2007 MAPK-mediated bimodal gene expression and adaptive gradient sensing in yeast. Nature 446, 46-51. (doi:10.1038/ nature05561)
75. Tyson JJ, Chen KC, Novak B. 2003 Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr. Opin. Cell Biol. 15, 221-231. (doi:10.1016/S0955-0674(03)00017-6)
76. Ferrell Jr JE. 2002 Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14, 140-148. (doi:10.1016/S0955-0674(02)00314-9)
77. Ma'Ayan A, Cecchi GA, Wagner J, Rao AR, Iyengar R, Stolovitzky G. 2008 Ordered cyclic motifs contribute to dynamic stability in biological and engineered networks. Proc. Natl Acad. Sci. USA 105, 19 235-19 240. (doi:10.1073/pnas.0805344105)
78. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. 1997 Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11, 1464-1478. (doi:10.1101/ gad.11.11.1464)
79. Aguda BD, Tang Y. 1999 The kinetic origins of the restriction point in the mammalian cell cycle. Cell Prolif. 32, 321-335. (doi:10.1046/j.1365-2184. 1999.3250321.x)
80. Novak B, Tyson JJ. 2004 A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 230, 563-579. (doi:10.1016/j.jtbi.2004. 04.039)
81. Hatzimanikatis V, Lee KH, Bailey JE. 1999 A mathematical description of regulation of the G1-S transition of the mammalian cell cycle. Biotechnol. Bioeng. 65, 631-637. (doi:10.1002/(SICI)1097-0290(19991220)65:6,631::AID-BIT3.3.0.CO;2-7)
82. Qu Z, MacLellan WR, Weiss JN. 2003 Dynamics of the cell cycle: checkpoints, sizers, and timers. Biophys. J. 85, 3600-3611. (doi:10.1016/S0006-3495(03)74778-X)
83. Thron CD. 1997 Bistable biochemical switching and the control of the events of the cell cycle. Oncogene 15, 317-325. (doi:10.1038/sj.onc.1201190)
84. Yao G, Lee TJ, Mori S, Nevins JR, You L. 2008 A bistable Rb-E2F switch underlies the restriction point. Nat. Cell Biol. 10, 476-482. (doi:10.1038/ ncb1711)
85. Yao G, Tan C, West M, Nevins JR, You L. 2011 Origin of bistability underlying mammalian cell cycle entry. Mol. Syst. Biol. 7, 485. (doi:10.1038/msb. 2011.19)
86. Lee T, Yao G, Bennett DC, Nevins JR, You L. 2010 Stochastic E2F activation and reconciliation of phenomenological cell-cycle models. PLoS Biol. 8, e1000488. (doi:10.1371/journal.pbio.1000488)
87. Eilers M, Schirm S, Bishop JM. 1991 The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10, 133-141.
88. Blomen VA, Boonstra J. 2007 Cell fate determination during G1 phase progression. Cell Mol. Life Sci. 64, 3084-3104. (doi:10.1007/s00018-007-7271-z)
89. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. 1996 Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA 93, 13 742-13 747. (doi:10.1073/pnas.93.24.13742)
90. Stein GH, Drullinger LF, Soulard A, Dulic V. 1999 Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell Biol. 19, 2109-2117.
91. Wang W, Martindale JL, Yang X, Chrest FJ, Gorospe M. 2005 Increased stability of the p16 mRNA with replicative senescence. EMBO Rep. 6, 158-164. (doi:10.1038/sj.embor.7400346)
92. Pajalunga D, Mazzola A, Puggioni E, Crescenzi M. 2007 Non-proliferation as an active state- conceptual and practical implications. Cell Cycle 6, 1415-1418. (doi:10.4161/cc.6.12.4378)
93. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. 2003 Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22, 4212-4222. (doi:10.1093/ emboj/cdg417)
94. Latella L, Sacco A, Pajalunga D, Tiainen M, Macera D, D'Angelo M, Felici A, Sacchi A, Crescenzi M. 2001 Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle. Mol. Cell Biol. 21, 5631-5643. (doi:10.1128/ MCB.21.16.5631-5643.2001)
95. Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999 Notch signaling: cell fate control and signal integration in development. Science 284, 770-776. (doi:10.1126/science.284.5415.770)
96. Bjornson CRR, Cheung TH, Liu L, Tripathi PV, Steeper KM, Rando TA. 2012 Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells 30, 232-242. (doi:10.1002/ stem.773)
97. Mourikis P, Sambasivan R, Castel D, Rocheteau P, Bizzarro V, Tajbakhsh S. 2012 A critical requirement for notch signaling in maintenance of the quiescent skeletal muscle stem cell state. Stem Cells 30, 243-252. (doi:10.1002/stem.775)
98. Sang L, Coller HA. 2009 Fear of commitment: Hes1 protects quiescent fibroblasts from irreversible cellular fates. Cell Cycle 8, 2161-2167. (doi:10. 4161/cc.8.14.9104)
99. Hartman J, Müller P, Foster JS, Wimalasena J, Gustafsson J, Ström A. 2004 HES-1 inhibits 17beta-estradiol and heregulin-beta1-mediated upregulation of E2F-1. Oncogene 23, 8826-8833. (doi:10.1038/sj.onc.1208139)
100. Kabos P, Kabosova A, Neuman T. 2002 Blocking HES1 expression initiates GABAergic differentiation and induces the expression of p21(CIP1/WAF1) in human neural stem cells. J. Biol. Chem. 277, 8763-8766. (doi:10.1074/jbc.C100758200)
101. Murata K, Hattori M, Hirai N, Shinozuka Y, Hirata H, Kageyama R, Sakai T, Minato N. 2005 Hes1 directly controls cell proliferation through the transcriptional repression of p27(Kip1). Mol. Cell. Biol. 25, 4262-4271. (doi:10.1128/MCB.25.10.4262-4271.2005)
102. Itahana K et al. 2002 A role for p53 in maintaining and establishing the quiescence growth arrest in human cells. J. Biol. Chem. 277, 18 206-18 214. (doi:10.1074/jbc.M201028200)
103. Liu Y et al. 2009 p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4, 37-48. (doi:10. 1016/j.stem.2008.11.006)
104. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, Orkin SH. 2004 Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431, 1002-1007. (doi:10.1038/nature02994)
105. Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, Nimer SD. 2006 The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 9, 175-187. (doi:10.1016/j.ccr.2006.02.017)
106. Kops GJ et al. 2002 Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321. (doi:10.1038/ nature01036)
107. Tothova Z et al. 2007 FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325-339. (doi:10.1016/j. cell.2007.01.003)
108. Maryanovich M, Oberkovitz G, Niv H, Vorobiyov L, Zaltsman Y, Brenner O, Lapidot T, Jung S, Gross A. 2012 The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells. Nat. Cell Biol. 14, 535-541. (doi:10.1038/ncb2468)
109. Rossig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S. 2001 Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell Biol. 21, 5644-5657. (doi:10.1128/MCB.21.16.5644-5657. 2001)
110. Zhou BP, Liao Y, Xia W, Spohn B, Lee M-H, Hung M-C. 2001 Cytoplasmic localization of p21Cip1/ WAF1 by Akt-induced phosphorylation in HER-2/ neu-overexpressing cells. Nat. Cell Biol. 3, 245-252. (doi:10.1038/35060032)
111. Takubo K et al. 2010 Regulation of the HIF-1 alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7, 391-402. (doi:10.1016/j.stem.2010.06. 020)
112. Gurumurthy S et al. 2010 The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468, 659-663. (doi:10.1038/nature09572)
113. Gan B et al. 2010 Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468, 701-704. (doi:10.1038/ nature09595)
114. Nakada D, Saunders TL, Morrison SJ. 2010 Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653-658. (doi:10.1038/nature09571)
115. Thompson BJ, Jankovic V, Gao J, Buonamici S, Vest A, Lee JM, Zavadil J, Nimer SD, Aifantis I. 2008 Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 205, 1395-1408. (doi:10.1084/jem.20080277)
116. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ. 2006 Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475-482. (doi:10.1038/nature04703)
117. Zhang J et al. 2006 PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441, 518-522. (doi:10.1038/ nature04747)
118. Ito K et al. 2008 PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453, 1072-1078. (doi:10.1038/nature07016)
119. Chen C, Liu Y, Liu R, Ikenoue T, Guan K-L, Liu Y, Zheng P. 2008 TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 205, 2397-2408. (doi:10. 1084/jem.20081297)
120. Blanchet E et al. 2011 E2F transcription factor-1 regulates oxidative metabolism. Nat. Cell Biol. 13, 1146-1152. (doi:10.1038/ncb2309)
121. Valentin M, Yang E. 2008 Autophagy is activated, but is not required for the G(0) function of BCL-2 or BCL-x(L). Cell Cycle 7, 2762-2768. (doi:10.4161/cc. 7.17.6595)
122. Dunn Jr WA. 1994 Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol. 4, 139-143. (doi:10. 1016/0962-8924(94)90069-8)
123. Klionsky DJ, Emr SD. 2000 Cell biology-autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721. (doi:10.1126/science.290. 5497.1717)
124. Rabinowitz JD, White E. 2010 Autophagy and metabolism. Science 330, 1344-1348. (doi:10. 1126/science.1193497)
125. Mortensen M et al. 2011 The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 208, 455-467. (doi:10. 1084/jem.20101145)
126. Chang YY, Neufeld TP. 2009 An Atg1/Atg13 complex with multiple roles in TOR-mediated autophagy regulation. Mol. Biol. Cell 20, 2004-2014. (doi:10. 1091/mbc.E08-12-1250)
127. Jung CH, Jun CB, Ro S-H, Kim Y-M, Otto NM, Cao J, Kundu M, Kim D-H. 2009 ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20, 1992-2003. (doi:10.1091/mbc.E08-12-1249)
128. Kamada Y, Yoshino K-I, Kondo C, Kawamata T, Oshiro N, Yonezawa K, Ohsumi Y. 2010 Tor directly controls the Atg1 kinase complex to regulate autophagy. Mol. Cell. Biol. 30, 1049-1058. (doi:10. 1128/MCB.01344-09)
129. Jiang H et al. 2010 The RB-E2F1 pathway regulates autophagy. Cancer Res 70, 7882-7893. (doi:10. 1158/0008-5472.CAN-10-1604)
130. Polager S, Ofir M, Ginsberg D. 2008 E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene 27, 4860-4864. (doi:10.1038/onc. 2008.117)
131. Cheung TH, Quach NL, Charville GW, Liu L, Park L, Edalati A, Yoo B, Hoang P, Rando TA. 2012 Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 482, 524-528. (doi:10. 1038/nature10834)
132. Arnold CP et al. 2011 MicroRNA programs in normal and aberrant stem and progenitor cells. Genome Res. 21, 798-810. (doi:10.1101/gr.111385.110)
133. Zhang L, Stokes N, Polak L, Fuchs E. 2011 Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment. Cell Stem Cell 8, 294-308. (doi:10. 1016/j.stem.2011.01.014)
134. Suh EJ et al. 2012 A microRNA network regulates proliferative timing and extracellular matrix synthesis during cellular quiescence in fibroblasts. Genome Biol. 13, R121. (doi:10.1186/gb-2012-13-12-r121)
135. Lechman ER et al. 2012 Attenuation of miR-126 activity expands hsc in vivo without exhaustion. Cell Stem Cell 11, 799-811. (doi:10.1016/j.stem.2012.09.001)
136. Boutet SC et al. 2012 Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. Cell Stem Cell 10, 327-336. (doi:10.1016/ j.stem.2012.01.017)
137. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. 2008 Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 320, 1643-1647. (doi:10.1126/science.1155390)
138. Mayr C, Bartel DP. 2009 Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673-684. (doi:10.1016/j.cell.2009.06.016)
139. Medina R, Zaidi SK, Liu C-G, Stein JL, vanWijnen AJ, Croce CM, Stein GS. 2008 MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res. 68, 2773-2780. (doi:10.1158/0008-5472.CAN-07-6754)
140. Gillies JK, Lorimer IA. 2007 Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6, 2005-2009. (doi:10.4161/cc.6. 16.4526)
141. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. 2007 MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67, 9762-9770. (doi:10.1158/ 0008-5472.CAN-07-2462)
142. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005 c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843. (doi:10.1038/nature03677)
143. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P. 2007 An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 282, 2135-2143. (doi:10.1074/jbc. M608939200)
144. Li Y, Zhang H, Chen Y. 2011 MicroRNA-mediated positive feedback loop and optimized bistable switch in a cancer network involving miR-17-92. PLoS ONE 6, e26302. (doi:10.1371/journal.pone. 0026302)
145. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB. 2008 MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc. Natl Acad. Sci. USA 105, 19 678-19 683. (doi:10.1073/ pnas.0811166106)
146. Bird A. 2002 DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21. (doi:10.1101/gad.947102)
147. Bernstein BE, Meissner A, Lander ES. 2007 The mammalian epigenome. Cell 128, 669-681. (doi:10.1016/j.cell.2007.01.033)
148. Turner BM. 2007 Defining an epigenetic code. Nat. Cell Biol. 9, 2-6. (doi:10.1038/ncb0107-2)
149. Srivastava S, Mishra RK, Dhawan J. 2010 Regulation of cellular chromatin state: insights from quiescence and differentiation. Organogenesis 6, 37-47. (doi:10.4161/org.6.1.11337)
150. Kamminga LM et al. 2006 The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 107, 2170-2179. (doi:10.1182/ blood-2005-09-3585)
151. Hidalgo I, Herrera-Merchan A, Ligos JM, Carramolino L, Nuñez J, Martinez F, Dominguez O, Torres M, Gonzalez S. 2012 Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest. Cell Stem Cell 11, 649-662. (doi:10.1016/j.stem.2012.08.001)
152. Ezhkova E, Lien W-H, Stokes N, Pasolli HA, Silva JM, Fuchs E. 2011 EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev. 25, 485-498. (doi:10.1101/gad.2019811)
153. Evertts AG, Manning AL, Wang X, Dyson NJ, Garcia BA, Coller HA. 2013 H4K20 methylation regulates quiescence and chromatin compaction. Mol. Biol. Cell 24, 3025-3037. (doi:10.1091/mbc.E12-07-0529)
154. Blais A, Dynlacht BD. 2007 E2F-associated chromatin modifiers and cell cycle control. Curr. Opin. Cell Biol. 19, 658-662. (doi:10.1016/j.ceb.2007.10.003)
155. Takeda S et al. 2006 Proteolysis of MLL family proteins is essential for Taspase1-orchestrated cell cycle progression. Genes Dev. 20, 2397-2409. (doi:10.1101/gad.1449406)
156. Tyagi S, Chabes AL, Wysocka J, Herr W. 2007 E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol. Cell 27, 107-119. (doi:10. 1016/j.molcel.2007.05.030)